Delivery Order SPE2DR25D1004-SPE2DR26FSUB0
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,163.90 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on September 26, 2025, with completion targeted for September 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to AmerisourceBergen's facility in...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $5,360.72 for Zepbound 7.5 mg/0.5 mL pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitive, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on November 14, 2025, with a ceiling value of $6,631.49 and an ultimate completion date of November 17, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $17.1K delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens with a completion date of September 22, 2025. This is a firm fixed-price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The contract specifies performance at...
- The Defense Logistics Agency awarded a $7,024.71 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Zepbound 10 mg/0.5 mL pens. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999 and running through December 2026. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 ml pens on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply services under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of...
- The Defense Logistics Agency awarded a $28,894.97 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with a completion deadline of October 29, 2025. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency has awarded a delivery order valued at $22,086.57 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pens under a firm fixed price contract. The award, dated September 15, 2025, with an ultimate completion date of September 16, 2025, represents a competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on October 17, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens with a ceiling value of approximately $14.8K. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 20, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed-price delivery order with no set-aside designation, demonstrating competitive award status. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. This delivery order is issued under...
- SPE2DR25D1004Indefinite Delivery Contract
- SPE2DR25D1004-SPE2DR26FSUB0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,772.44 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pens on October 28, 2025, with completion targeted for October 29, 2025. This competitively awarded, firm fixed price delivery order represents a non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 pharmaceutical support vehicle running through December 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp maintains an extensive portfolio of delivery orders with DLA covering diverse pharmaceutical products including specialty medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Zepbound, a diabetes and weight management medication, reflects the company's critical role in supporting military healthcare systems and other government agencies through the DLA Medical Supply Chain's flexible contracting vehicle, which enables rapid fulfillment of pharmaceutical requirements to support federal health programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 10/28/25 |